This intellectual property portfolio showcases a diverse range of innovative technologies targeting autoimmune and inflammatory diseases. The portfolio includes cutting-edge cell and gene therapies, advanced diagnostic tools, and novel small molecule therapies and drug discovery platforms. These inventions aim to provide more effective and personalized treatment options for patients suffering from conditions such as IPEX syndrome, osteoarthritis, multiple sclerosis, and severe allergic reactions.
This collection features inventions from Stanford's pioneering researchers such as Rosa Bacchetta, Maria-Grazia Roncarolo, Matthew Porteus, Mark Davis, Nidhi Bhutani, William Robinson, and Vinit Mahajan.